1. Sunitinib malate (Sutent®) Medical Review, NDA 21–938 (GIST), NDA-21-968 (MRCC). FDA; January 2006.
2. Sunitinib malate (Sutent®) Pharmacological Review, NDA 21–938; January 2006.
3. Sunitinib malate (Sutent®) Approval Package for 21-938/S-002; 003; 004; 005, and for 21-968/S-002; 003; 004; 005; 006. FDA; February 2007.
4. Sutent® (Sunitinib malate) Prescribing Information. Pfizer; December 2014.
5. Sutent® (Sunitinib malate) Scientific Discussion WC500057733. EMEA; January 2007.